Next Article in Journal
Integrating Primary Care Providers through the Seasons of Survivorship
Previous Article in Journal
A Case of Nivolumab-Induced Acute-Onset Type 1 Diabetes Mellitus in Melanoma
 
 

Order Article Reprints

Journal: Curr. Oncol., 2019
Volume: 26
Number: 4809

Article: Brigatinib is another treatment option for patients diagnosed with advanced ALK-positive non-small-cell lung cancer who are treatment-naïve or who have progressed on or are intolerant to crizotinib
Authors: by Barbara Melosky, Parneet Cheema and Geoffrey Liu
Link: https://www.mdpi.com/1718-7729/26/1/4809

MDPI provides article reprints in high quality with convenient shipping to destinations worldwide. The articles are printed in on premium paper with high-resolution figures. Our covers are customized to your article and designed to be complimentary to the journal. These reprints are ideal additions to your portfolio. Copy details: 135g/m2 paper, 2x stitched, full colour and glossy finish, orderable in quantities from 10 to 1000.

If you have any questions, or special requests, please write to our support team; we are happy to provide you with the information you need.

Reprint Options

If you need more than 400 copies, please contact us by e-mail (publisher@mdpi.com) and we will prepare an individual offer for you.

Order Cost and Details

Contact Person

Invoice Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop